Zimmer Biomet extends TMINI deal: Zimmer Biomet stock is valued at USD 18.1 billion

Published on 10/20/2026 at 14:06 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

The deal keeps one TMINI system with Persona; Q2 revenue rose 4.80 percent. Zimmer Biomet stock traded at EUR 84.80 on October 20, 2026.

Robotics deal and earnings dates

Zimmer Biomet extended its TMINI distribution agreement on October 13, 2026.
Second-quarter revenue rose 4.80 percent to USD 2.18 billion.
Zimmer Biomet stock traded at EUR 84.80 at 2:02 p.m. CEST at Lang & Schwarz on October 20, 2026.

Zimmer Biomet US98956P1021 als Bauhaus-Poster mit geometrischem Kniegelenk-Motiv und Sektor-Schriftzug MEDTECH in Primärfarben, Illustration mit AI erstellt.

Zimmer Biomet (US98956P1021) extended its exclusive TMINI distribution agreement with THINK Surgical on October 13, 2026. The multi-year deal keeps one wireless, handheld robotic system compatible with Zimmer Biomet's Persona Knee System, according to Zimmer Biomet.

Revenue gives the deal context

Zimmer Biomet's second-quarter 2026 revenue reached USD 2.18 billion, up 4.80 percent from the prior-year quarter. Adjusted earnings per share came to USD 2.07, compared with a USD 2.01 consensus estimate, while fiscal 2026 adjusted earnings-per-share guidance stood at USD 8.47-8.59, according to MarketBeat. The figures make robotics a strategic extension of an established orthopedic platform rather than a standalone financial driver.

Three dated steps in the story

On August 5, 2026, Zimmer Biomet reported USD 2.18 billion in quarterly revenue and adjusted earnings per share of USD 2.07. On October 6, 2026, it scheduled the third-quarter results for November 4, 2026, at 6:30 a.m. ET, as stated by Zimmer Biomet. On October 13, 2026, the company announced the multi-year extension covering one exclusive TMINI system.

What comes next for Zimmer Biomet?

The next scheduled reporting date is November 4, 2026. A quarterly dividend of USD 0.24 per share is scheduled for payment on October 30, 2026, according to MarketBeat. For investors, the November report will show whether the 4.80 percent revenue growth carried into the second half.

Robotics meets the next results date

The distribution extension broadens Zimmer Biomet's robotic offering around the Persona platform, while financial terms and the contract duration were not disclosed. Market capitalization stood at USD 18.1 billion as of October 19, 2026, and the company operates in medical devices.

Zimmer Biomet was trading at EUR 84.80 at Lang & Schwarz on October 20, 2026 at 2:02 p.m. CEST.

The further course of trading is shown by the continuously updated real-time quote of Zimmer Biomet stock.